Lijun Says Enerxin Capsules Effective in Treating H1N1 Flu
publication date: Nov 10, 2009
Lijun International Pharmaceutical (Holding) Co., Ltd. reported that its Enerxin Capsules, an antiviral drug, was recognized by the State Key Laboratory of Virology for effective restraint of the growth of influenza A (H1N1). The effects of the drug were similar to Tamiflu. Enerxin was developed by a subsidiary of Lijun, Shijiazhuang No.4 Pharmaceutical Co., Ltd. More details...
Stock Symbol: (HKEX: 2005)
Sorry... this feature or article is only available to subscribers.